• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 - 2023年中国深圳608名女性宫颈人乳头瘤病毒感染的结局及相关因素

Outcomes and associated factors of cervical human papillomavirus infection among 608 women in Shenzhen, China, 2018-2023.

作者信息

Lv Zhenghan, He Xuesen, Li Zhiju, Yuan Yue, Zhou Xinyi, Tu Changqing, Yang Yinqi, Huang Yanshan, Yin Lili, Chen Huihui, Tao Yanling

机构信息

Clinical Medical College of Shenzhen, Guangzhou University of Chinese Medicine, Shenzhen, China.

Department of Preventive and Health Care, Longgang District Central Hospital of Shenzhen, Shenzhen, China.

出版信息

Front Public Health. 2025 Jan 14;12:1523839. doi: 10.3389/fpubh.2024.1523839. eCollection 2024.

DOI:10.3389/fpubh.2024.1523839
PMID:39877908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772415/
Abstract

OBJECTIVE

This study aimed to uncover the patterns of Human papillomavirus (HPV) infection outcomes in women and assess the risk factors that may affect these outcomes.

METHODS

A retrospective study was conducted on 608 women who tested positive for HPV-DNA during their initial visit to the outpatient department of Shenzhen Longgang Central Hospital from 2018 to 2023 and who had subsequent HPV-DNA testing as part of their post-visit monitoring. The monitoring intervals were every 6 months. The rank sum test was used to analyze ranked data. The Kaplan-Meier method was used to analyze the turning negative time. Univariate analysis was performed using the log-rank test, and multivariate analysis was performed using the Cox model to analyze independent risk factors.

RESULTS

The results showed that the median age was 40.00 years (interquartile 33.00-47.00 years), the total conversion rate of the HPV-negative patients was 38.98%, and the median conversion time of the HPV-negative patients was 8.95 months (interquartile 4.20-16.175 months). Age, infection status and type of health insurance were significantly correlated with HPV outcome ( < 0.05).

CONCLUSION

Among women infected with HPV, the overall rate of negative HPV infection was 38.93%, and the duration of negative conversion was 8.95 months. The study revealed that age, HPV infection status, and type of medical insurance are independent predictors of the persistence of negative HPV test outcomes.

摘要

目的

本研究旨在揭示女性人乳头瘤病毒(HPV)感染结局的模式,并评估可能影响这些结局的危险因素。

方法

对2018年至2023年首次到深圳龙岗中心医院门诊就诊时HPV-DNA检测呈阳性且后续进行HPV-DNA检测作为复诊监测一部分的608名女性进行回顾性研究。监测间隔为每6个月。采用秩和检验分析等级资料。采用Kaplan-Meier法分析转阴时间。单因素分析采用对数秩检验,多因素分析采用Cox模型分析独立危险因素。

结果

结果显示,中位年龄为40.00岁(四分位间距33.00 - 47.00岁),HPV阴性患者的总转化率为38.98%,HPV阴性患者的中位转阴时间为8.95个月(四分位间距4.20 - 16.175个月)。年龄、感染状态和医疗保险类型与HPV结局显著相关(<0.05)。

结论

在感染HPV的女性中,HPV感染转阴的总体率为38.93%,转阴持续时间为8.95个月。该研究表明,年龄、HPV感染状态和医疗保险类型是HPV检测结果持续阴性的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/9da9b87f1b12/fpubh-12-1523839-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/ee17608ab12c/fpubh-12-1523839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/7673102d5504/fpubh-12-1523839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/9da9b87f1b12/fpubh-12-1523839-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/ee17608ab12c/fpubh-12-1523839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/7673102d5504/fpubh-12-1523839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc2d/11772415/9da9b87f1b12/fpubh-12-1523839-g003.jpg

相似文献

1
Outcomes and associated factors of cervical human papillomavirus infection among 608 women in Shenzhen, China, 2018-2023.2018 - 2023年中国深圳608名女性宫颈人乳头瘤病毒感染的结局及相关因素
Front Public Health. 2025 Jan 14;12:1523839. doi: 10.3389/fpubh.2024.1523839. eCollection 2024.
2
Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.高危型人乳头瘤病毒感染无宫颈病变的结局及其相关因素。
BMC Womens Health. 2023 Nov 14;23(1):599. doi: 10.1186/s12905-023-02764-8.
3
[Analysis of human papillomavirus subtype distribution and cervical lesion characteristics in a cancer hospital in Shenzhen City].[深圳市某肿瘤医院人乳头瘤病毒亚型分布及宫颈病变特征分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Apr 6;59(4):490-494. doi: 10.3760/cma.j.cn112150-20241004-00788.
4
[Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].[特定型别人类乳头瘤病毒对宫颈癌前病变的风险分层:来自深圳一项横断面研究的证据]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):757-763. doi: 10.3760/cma.j.issn.0253-3766.2018.10.007.
5
[Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen].[深圳成年女性高危型人乳头瘤病毒及宫颈癌患病率调查]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):799-802.
6
Epidemiological survey and risk factor analysis of high-risk human papillomavirus in women in Longgang District, Shenzhen.深圳龙岗区女性高危型人乳头瘤病毒的流行病学调查及危险因素分析
Altern Ther Health Med. 2024 Sep;30(9):90-94.
7
Predictors of Human papillomavirus (HPV) persistence after treatment of high grade cervical lesions; does cervical cytology have any prognostic value in primary HPV screening?治疗高级别宫颈病变后 HPV 持续感染的预测因素;宫颈细胞学在原发性 HPV 筛查中有预后价值吗?
Ann Diagn Pathol. 2020 Dec;49:151626. doi: 10.1016/j.anndiagpath.2020.151626. Epub 2020 Sep 8.
8
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.HPV 检测与常规细胞学检查在宫颈癌筛查中的比较:ARTISTIC RCT 的长期随访。
Health Technol Assess. 2019 Jun;23(28):1-44. doi: 10.3310/hta23280.
9
Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.中国最大的经美国病理学家学会(CAP)认证的实验室对427例浸润性宫颈癌进行的既往高危人乳头瘤病毒(HPV)检测和巴氏试验结果。
Cancer Cytopathol. 2015 Jul;123(7):428-34. doi: 10.1002/cncy.21557. Epub 2015 May 8.
10
Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.中国 HIV 感染者中宫颈上皮内瘤变与 HPV 感染及其相关因素的横断面研究
Sex Transm Infect. 2019 Mar;95(2):140-144. doi: 10.1136/sextrans-2018-053636. Epub 2018 Oct 18.

本文引用的文献

1
Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis.女性单一和多重人乳头瘤病毒感染模式:一项系统评价和荟萃分析。
Heliyon. 2024 Aug 18;10(17):e35736. doi: 10.1016/j.heliyon.2024.e35736. eCollection 2024 Sep 15.
2
Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review.通过联合治疗和改进的传递策略增强 HPV 治疗性肽疫苗的功效:综述。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2396710. doi: 10.1080/21645515.2024.2396710. Epub 2024 Aug 28.
3
Menopause in adult women with human papillomavirus: health-related quality of life and determinants.
成年女性的人乳头瘤病毒感染与绝经期:健康相关生活质量及其决定因素。
Menopause. 2024 Sep 1;31(9):809-817. doi: 10.1097/GME.0000000000002395. Epub 2024 Aug 5.
4
Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years.多重人乳头瘤病毒感染模式与型别竞争:一项针对18至45岁中国健康女性的分析
Hum Vaccin Immunother. 2024 Dec 31;20(1):2334474. doi: 10.1080/21645515.2024.2334474. Epub 2024 Apr 15.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
[Cancer incidence and mortality in China, 2022].[2022年中国癌症发病率和死亡率]
Zhonghua Zhong Liu Za Zhi. 2024 Mar 23;46(3):221-231. doi: 10.3760/cma.j.cn112152-20240119-00035.
7
Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus Type-Specific Attribution.单一型与多型人乳头瘤病毒感染与宫颈上皮内瘤变 2/3 及鳞状细胞癌病变的相关性:人乳头瘤病毒型特异性归因。
Lab Invest. 2024 Apr;104(4):100328. doi: 10.1016/j.labinv.2024.100328. Epub 2024 Jan 16.
8
Trends in cervical cancer screening in Norway 2012-2017: a comparison study of non-immigrant and immigrant women.2012 - 2017年挪威宫颈癌筛查趋势:非移民和移民女性的比较研究
Scand J Public Health. 2024 Dec;52(8):927-933. doi: 10.1177/14034948231217636. Epub 2024 Jan 2.
9
Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis.人乳头瘤病毒疫苗的疗效比较:系统评价和网络荟萃分析。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):1168-1178. doi: 10.1080/14760584.2023.2287135. Epub 2023 Nov 27.
10
Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.高危型人乳头瘤病毒感染无宫颈病变的结局及其相关因素。
BMC Womens Health. 2023 Nov 14;23(1):599. doi: 10.1186/s12905-023-02764-8.